Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04676477
Title Patritumab Deruxtecan in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Daiichi Sankyo, Inc.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Recruiting Santa Monica California 90404 United States Details
Georgetown University Medical Center Recruiting Washington District of Columbia 20057 United States Details
Massachusetts General Hospital Cancer Center Recruiting Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Recruiting Boston Massachusetts 02215-5450 United States Details
Dartmouth-Hitchcock Medical Center Recruiting Lebanon New Hampshire 03756 United States Details
Columbia University Irving Medical Center Recruiting New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10065 United States Details
Sarah Cannon and HCA Research Institute Recruiting Nashville Tennessee 37203 United States Details
Virginia Cancer Specialists, PC Recruiting Fairfax Virginia 22031 United States Details
National Cancer Center Hospital Recruiting Chuo Ku Tokyo 104-0045 Japan Details
National Hospital Organization Kyushu Cancer Center Recruiting Fukuoka 811-1347 Japan Details
Shizuoka Cancer Center Recruiting Shizuoka 411-8777 Japan Details
The Cancer Institute Hospital of JFCR Recruiting Tokyo 135-8550 Japan Details
Kanagawa Cancer Center Recruiting Yokohama 241-8515 Japan Details
Kindai University Hospital Recruiting Ōsaka-sayama 589-8511 Japan Details
*Shaded cells indicate that there was no data available from for the field